tradingkey.logo

Insulet Corp

PODD
View Detailed Chart

252.290USD

+1.019+0.41%
Close 04/30, 16:00ETQuotes delayed by 15 min
17.71BMarket Cap
42.34P/E TTM

Insulet Corp

252.290

+1.019+0.41%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.41%

5 Days

+2.35%

1 Month

-12.49%

6 Months

+8.97%

Year to Date

-3.36%

1 Year

+46.73%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 25 analysts
BUY
Current Rating
316.778
Target Price
26.07%
Rising Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

111
Total
7
Median
9
Average
Company name
Ratings
Analysts
Insulet Corp
PODD
25
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
28
Dexcom Inc
DXCM
26
1
2
3
...
22

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(6)
Neutral(5)
Buy(2)
Indicators
Sell(2)
Neutral(5)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
2.221
Neutral
RSI(14)
44.897
Neutral
STOCH(KDJ)(9,3,3)
69.000
Neutral
ATR(14)
11.429
Low Volatility
CCI(14)
4.313
Neutral
Williams %R
46.468
Neutral
TRIX(12,20)
-0.372
Sell
StochRSI(14)
37.466
Sell
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
255.474
Sell
MA10
251.391
Buy
MA20
253.860
Sell
MA50
268.207
Sell
MA100
263.728
Sell
MA200
236.038
Buy

News

More news coming soon, stay tuned...

Company

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, the Omnipod Insulin Management System, and Omnipod GO. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen's Neulasta. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. Omnipod 5 includes an AID algorithm embedded in the Pod.
Company codePODD
CompanyInsulet Corp
CEOMs. Ashley Mcevoy
Websitehttps://www.omnipod.com